Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Orion OYJ Net Income 2017-2023 | ORINY

Orion OYJ annual/quarterly net income history and growth rate from 2017 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Orion OYJ net income for the quarter ending September 30, 2023 was $0.067B, a 65.89% decline year-over-year.
  • Orion OYJ net income for the twelve months ending September 30, 2023 was $0.191B, a 47.89% decline year-over-year.
  • Orion OYJ annual net income for 2022 was $0.368B, a 60.6% increase from 2021.
  • Orion OYJ annual net income for 2021 was $0.229B, a 8.72% decline from 2020.
  • Orion OYJ annual net income for 2020 was $0.251B, a 11.92% increase from 2019.
  
Orion OYJ Annual Net Income
(Millions of US $)
2022 $368
2021 $229
2020 $251
2019 $224
2018 $390
2017 $255
2016 $276
Orion OYJ Quarterly Net Income
(Millions of US $)
2023-09-30 $67
2023-06-30 $40
2023-03-31 $47
2022-12-31 $38
2022-09-30 $196
2022-06-30 $70
2022-03-31 $64
2021-12-31 $36
2021-09-30 $54
2021-06-30 $67
2021-03-31 $72
2020-12-31 $34
2020-09-30 $60
2020-06-30 $83
2020-03-31 $74
2019-12-31 $50
2019-09-30 $80
2019-06-30 $46
2019-03-31 $49
2018-12-31 $59
2018-09-30 $40
2018-06-30 $221
2018-03-31 $70
2017-12-31 $67
2017-09-30 $52
2017-06-30 $62
2017-03-31 $75
2016-12-31 $51
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $5.081B $1.288B
Orion Oyj is a pharmaceutical company. It develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company's core therapy consists of central nervous system disorders, oncology and respiratory. Its product pipeline includes inhaled Easyhaler(R) pulmonary drugs. Orion Oyj is headquartered in Espoo, Finland.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $68.499B 28.15
Chugai Pharmaceutical (CHGCY) Japan $53.594B 23.27
Takeda Pharmaceutical (TAK) Japan $41.712B 6.76
Merck (MKGAF) Germany $20.937B 19.76
Astellas Pharma (ALPMY) Japan $16.778B 23.77
Shionogi (SGIOY) Japan $14.250B 12.33
Sandoz Group AG (SDZNY) $13.124B 0.00
Neurocrine Biosciences (NBIX) United States $13.109B 54.44
United Therapeutics (UTHR) United States $11.063B 11.85
Catalent (CTLT) United States $10.136B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.572B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.987B 7.09
Ionis Pharmaceuticals (IONS) United States $6.056B 0.00
Revolution Medicines (RVMD) United States $5.853B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.341B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.604B 0.00
Alpine Immune Sciences (ALPN) United States $4.222B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.040B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.975B 0.00
Indivior (INDV) United States $2.722B 12.65
Evotec AG (EVO) Germany $2.569B 0.00
Summit Therapeutics (SMMT) United States $2.565B 0.00
Corcept Therapeutics (CORT) United States $2.396B 24.37
Dyne Therapeutics (DYN) United States $2.192B 0.00
PTC Therapeutics (PTCT) United States $1.967B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.828B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.816B 18.77
Fusion Pharmaceuticals (FUSN) Canada $1.806B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.762B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.701B 10.07
Taro Pharmaceutical Industries (TARO) Israel $1.583B 27.71
Ardelyx (ARDX) United States $1.582B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.540B 0.00
4D Molecular Therapeutics (FDMT) United States $1.343B 0.00
Soleno Therapeutics (SLNO) United States $1.250B 0.00
Pacira BioSciences (PCRX) United States $1.234B 12.28
Xencor (XNCR) United States $1.229B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.219B 11.46
Ocular Therapeutix (OCUL) United States $1.159B 0.00
Collegium Pharmaceutical (COLL) United States $1.149B 7.07
Centessa Pharmaceuticals (CNTA) United Kingdom $1.081B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.963B 0.00
Cronos Group (CRON) Canada $0.932B 0.00
Sage Therapeutics (SAGE) United States $0.921B 0.00
Relay Therapeutics (RLAY) United States $0.896B 0.00
ARS Pharmaceuticals (SPRY) United States $0.892B 0.00
Cassava Sciences (SAVA) United States $0.865B 0.00
USANA Health Sciences (USNA) United States $0.836B 13.17
Enliven Therapeutics (ELVN) United States $0.822B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.729B 0.00
Savara (SVRA) United States $0.696B 0.00
Siga Technologies (SIGA) United States $0.631B 9.35
Silence Therapeutics (SLN) United Kingdom $0.618B 0.00
Verve Therapeutics (VERV) United States $0.611B 0.00
Lyell Immunopharma (LYEL) United States $0.610B 0.00
Korro Bio (KRRO) United States $0.597B 0.00
OmniAb (OABI) United States $0.580B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.565B 0.00
Altimmune (ALT) United States $0.535B 0.00
Exscientia (EXAI) United Kingdom $0.527B 0.00
KalVista Pharmaceuticals (KALV) United States $0.495B 0.00
Tourmaline Bio (TRML) United States $0.487B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.482B 0.00
ProKidney (PROK) United States $0.479B 0.00
Larimar Therapeutics (LRMR) United States $0.466B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.449B 0.00
Heron Therapeutics (HRTX) United States $0.443B 0.00
Harrow (HROW) United States $0.437B 0.00
Lexeo Therapeutics (LXEO) United States $0.398B 0.00
Bioventus (BVS) United States $0.367B 0.00
Esperion Therapeutics (ESPR) United States $0.366B 0.00
Organogenesis (ORGO) United States $0.364B 69.00
Nature's Sunshine Products (NATR) United States $0.349B 19.52
Enanta Pharmaceuticals (ENTA) United States $0.342B 0.00
ESSA Pharma (EPIX) Canada $0.323B 0.00
Metagenomi (MGX) United States $0.320B 0.00
Fractyl Health (GUTS) United States $0.318B 0.00
Lyra Therapeutics (LYRA) United States $0.315B 0.00
Prelude Therapeutics (PRLD) United States $0.309B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.294B 0.00
Akebia Therapeutics (AKBA) United States $0.291B 0.00
Aquestive Therapeutics (AQST) United States $0.289B 0.00
Nektar Therapeutics (NKTR) United States $0.288B 0.00
Adherex Technologies (FENC) United States $0.280B 0.00
Pyxis Oncology (PYXS) United States $0.276B 0.00
Foghorn Therapeutics (FHTX) United States $0.272B 0.00
Black Diamond Therapeutics (BDTX) United States $0.270B 0.00
Nanobiotix S.A (NBTX) France $0.263B 0.00
Telomir Pharmaceuticals (TELO) United States $0.262B 0.00
Xeris Biopharma Holdings (XERS) United States $0.260B 0.00
Aldeyra Therapeutics (ALDX) United States $0.245B 0.00
Avita Medical (RCEL) United States $0.243B 0.00
Galectin Therapeutics (GALT) United States $0.242B 0.00
Century Therapeutics (IPSC) United States $0.238B 0.00
Conduit Pharmaceuticals (CDT) United States $0.234B 0.00
Acrivon Therapeutics (ACRV) United States $0.218B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Zevra Therapeutics (ZVRA) United States $0.208B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.202B 0.00
Profound Medical (PROF) Canada $0.193B 0.00
Regulus Therapeutics (RGLS) United States $0.182B 0.00
Incannex Healthcare (IXHL) Australia $0.168B 0.00
VAXART, INC (VXRT) United States $0.158B 0.00
Achieve Life Sciences (ACHV) Canada $0.152B 0.00
MediWound (MDWD) Israel $0.152B 0.00
GlycoMimetics (GLYC) United States $0.145B 0.00
Inotiv (NOTV) United States $0.145B 0.00
Elite Pharmaceuticals (ELTP) United States $0.144B 13.50
CytoDyn (CYDY) United States $0.144B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.140B 2.96
Relmada Therapeutics (RLMD) United States $0.134B 0.00
OptiNose (OPTN) United States $0.134B 0.00
Karyopharm Therapeutics (KPTI) United States $0.133B 0.00
Eliem Therapeutics (ELYM) United States $0.132B 0.00
FibroGen (FGEN) United States $0.129B 0.00
Cardiol Therapeutics (CRDL) Canada $0.122B 0.00
Citius Pharmaceuticals (CTXR) United States $0.122B 0.00
ProPhase Labs (PRPH) United States $0.111B 0.00
Vivani Medical (VANI) United States $0.111B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.097B 0.00
Aclaris Therapeutics (ACRS) United States $0.086B 0.00
AlloVir (ALVR) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
PMV Pharmaceuticals (PMVP) United States $0.084B 0.00
Journey Medical (DERM) United States $0.080B 0.00
Assertio Holdings (ASRT) United States $0.077B 6.26
Tempest Therapeutics (TPST) United States $0.074B 0.00
Carisma Therapeutics (CARM) United States $0.073B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.071B 0.00
Mural Oncology (MURA) $0.069B 0.00
Champions Oncology (CSBR) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.056B 0.83
Reneo Pharmaceuticals (RPHM) United States $0.055B 0.00
BioLineRx (BLRX) Israel $0.051B 0.00
Gain Therapeutics (GANX) United States $0.050B 0.00
NRx Pharmaceuticals (NRXP) United States $0.047B 0.00
Rafael Holdings (RFL) United States $0.045B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
Unicycive Therapeutics (UNCY) United States $0.040B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.040B 0.00
VYNE Therapeutics (VYNE) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
CASI Pharmaceuticals (CASI) China $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.033B 0.00
Protara Therapeutics (TARA) United States $0.032B 0.00
Nutriband (NTRB) United States $0.031B 0.00
Viracta Therapeutics (VIRX) United States $0.031B 0.00
Lipocine (LPCN) United States $0.028B 0.00
Aptorum Group (APM) United Kingdom $0.028B 0.00
JanOne (JAN) United States $0.026B 0.00
Addex Therapeutics (ADXN) Switzerland $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
CERo Therapeutics Holdings (CERO) United States $0.026B 0.00
DURECT (DRRX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Oncternal Therapeutics (ONCT) United States $0.024B 0.00
TherapeuticsMD (TXMD) United States $0.022B 0.00
Alaunos Therapeutics (TCRT) United States $0.022B 0.00
Indaptus Therapeutics (INDP) United States $0.022B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 10.33
MEI Pharma (MEIP) United States $0.022B 1.09
PolyPid (PYPD) Israel $0.022B 0.00
Surrozen (SRZN) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Dominari Holdings (DOMH) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Avalo Therapeutics (AVTX) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.015B 0.00
Inhibikase Therapeutics (IKT) United States $0.014B 0.00
Biomerica (BMRA) United States $0.013B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.012B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Clever Leaves Holdings (CLVR) Canada $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 47.50